+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Mitchell A. Baran Achievement Award for Clinical Excellence in Aerosol and Airway Clearance Therapies

American Respiratory Care Foundation

This annual achievement award was established in 2016 to honor the memory and legacy of Dr. Mitchell A. Baran, founder and former Chairman of Monaghan Medical Corporation (USA) and the Trudell Medical Group (Global). The companies and their affiliates are leading innovators in the evidence-based delivery of aerosolized medications and airway clearance therapies, as well as other medical devices and services.

Throughout his long and distinguished career, Dr. Mitchell Baran was unwavering in his commitment to the necessity of basing respiratory care product development, and subsequent application, on a foundation of established scientific evidence, coupled with the clinical expertise of those using such products. As result, respiratory devices developed under his tenure have had an impact on patient’s health in the US and around the globe.

An endowment has been established with the American Respiratory Care Foundation (ARCF) to recognize and honor individuals demonstrating clinical excellence and advocacy for evidence-based, clinically sound practices for aerosolized medication delivery and/or the application of non-pharmacologic airway clearance therapies.

In the year the award is bestowed, recipients will receive a cash prize of $2,500, an engraved crystal trophy, round-trip coach airfare, with two nights lodging and registration to the annual International Congress of The American Association for Respiratory Care (AARC).

AI Based Application Success Predictor

🫁 1. Strong Focus on Respiratory Care & Pulmonary Health (Non-Negotiable)

Projects must directly relate to:
- Respiratory care, pulmonary disease management, or respiratory therapy practice

Common focus areas:

Mechanical ventilation
COPD
Asthma
Critical care
Neonatal/pediatric respiratory care
Sleep and airway disorders

👉 Non-respiratory clinical topics → low success probability

🎯 2. Clear Clinical Impact on Respiratory Patient Care (Top Predictor)

ARCF strongly prioritizes:
- Research improving:
  - Respiratory outcomes
  - Patient safety
  - Clinical effectiveness
  - Quality of care

👉 Key question:
“Will this improve respiratory patient outcomes or respiratory care practice?”

🔄 3. Practice-Oriented & Translational Research (Critical)

Strong preference for:
- Applied clinical respiratory care studies
- Bedside implementation research
- Evidence-based practice improvement

👉 Pure bench/basic pulmonary science without respiratory care application is less competitive.

👩‍⚕️ 4. Respiratory Therapist–Led Research & Workforce Development (Major Priority)

A defining feature of ARCF:
- Strong support for:
  - Respiratory therapists
  - educator-researchers
  - clinical workforce advancement

👉 Projects led by or directly benefiting respiratory care professionals score highly.

📊 5. Strong Methodology & Measurable Outcomes

Competitive proposals usually include:

Clearly defined respiratory endpoints
Practical clinical metrics
Quality-improvement measures
Feasible data collection plans

👉 Weak study design is a common rejection factor.

🚀 6. Innovation in Respiratory Care Delivery

High-success areas include:

Ventilator management innovation
Remote respiratory monitoring
AI-assisted respiratory support
Tele-respiratory care
Pulmonary rehabilitation innovation

👉 Innovation must improve real-world respiratory practice.

🧪 7. Feasible, Small-to-Mid Scale Clinical Projects

ARCF funding is often:
- Pilot-scale or practice-improvement oriented

👉 Competitive projects:

Have realistic recruitment and implementation plans
Fit the available budget and timeline

🤝 8. Interdisciplinary Clinical Collaboration

Strong projects often involve:

Pulmonologists
Critical care teams
Nursing
Rehabilitation specialists
Sleep medicine professionals

👉 Team-based respiratory care research performs well.

🌍 9. Patient Education & Preventive Respiratory Care

Increasing emphasis on:
- Self-management
- Pulmonary rehabilitation
- Chronic disease prevention
- Community respiratory health

👉 Preventive respiratory care projects are increasingly competitive.

👩‍🔬 10. Student & Early-Career Research Development

ARCF strongly supports:
- Respiratory therapy students
- Emerging clinician-researchers
- Academic career development

👉 Educational and mentorship components strengthen applications.

📈 11. Dissemination & Clinical Practice Impact

Competitive proposals include:

Plans for:
- Publications
- Conference presentations
- Clinical protocol implementation
- Educational dissemination

👉 Potential to influence respiratory care practice matters greatly.

🌐 12. Alignment with High-Burden Respiratory Diseases

Historically competitive areas include:

COPD
Asthma
ARDS
Mechanical ventilation
Neonatal respiratory disease
Long-COVID pulmonary rehabilitation

👉 High-burden respiratory conditions improve strategic relevance.

📊 Summary: Key Predictors (Ranked)

🔥 Highest impact factors:

Respiratory care-specific focus
Clinical/patient care impact
Practice-oriented translational relevance

⚖️ Major differentiators:

Respiratory therapist/workforce relevance
Strong methodology
Innovation in respiratory care delivery

📌 Supporting factors:

Feasibility
Interdisciplinary collaboration
Preventive/community respiratory health
Dissemination potential

💡 Insider Insight

Compared to NIH pulmonary funding:

American Respiratory Care Foundation is:
👉 highly focused on:
- bedside respiratory care
- clinical implementation
- respiratory therapy workforce advancement
- practical patient outcome improvement

👉 Winning formula:
Respiratory care-focused clinical project + measurable patient benefit + practical implementation + strong respiratory therapist involvement

✔️ What wins:

Ventilation and ICU respiratory care studies
COPD/asthma management innovation
Respiratory therapy workforce and education projects
Pulmonary rehabilitation and preventive care research

❌ What struggles:

Pure bench pulmonary biology
Weak clinical applicability
Non-respiratory projects
Overly complex studies without implementation feasibility

Specialties

Pulmonology

Eligibility Requirements

At the beginning of each calendar year, the ARCF Achievement Award Selection Committee will invite nominations for the Mitchell A. Baran Achievement Award (MAB Award). A call for nominations shall be periodically posted to each of the AARC’s Specialty Section Digests and shall include the date by which all completed nominations shall be received by the Achievement Award Selection Committee. The posting should also include mention of Dr Baran’s legacy (as stated in the first 2 paragraphs of this document), and the nomination criteria as set forth below.

Eligible candidates will, at a minimum, possess the registered respiratory therapist (RRT) credential and be an active member of the AARC for a minimum of five consecutive years, but no more than fifteen. It is anticipated that nominees will also have a record of voluntary service to the AARC and/or related professional organizations, with special emphasis given to those individuals exhibiting demonstrable clinical skills.

A completed nomination must include the following:

A description of the nominee’s professional background (i.e. a current curriculum vitae)
A detailed narrative describing the nominee’s achievements in advocating and promoting excellence in the delivery of aerosolized mediations, airway clearance therapy and the impact such activities have had on patients, their families, and other clinicians, and
A brief description of any in-vivo studies undertaken and published by the nominee to further strengthen the knowledge base and clinical application of evidence-driven aerosol drug delivery, and non-pharmacologic airway clearance therapy.

Completed nominations must be received by the ARCF Achievement Award Selection Committee no later than June 1st of the calendar year in which the award is to be bestowed. The Selection Committee will, in turn, review all completed nominations and make the determination of the award recipient. Nominations for prior recipients of the MAB Award shall not be considered.

Upon selection, the successful nominee’s contact information shall be forwarded to the ARCF who, in turn, will notify the award recipient and invite them to attend the Award Ceremony, held in conjunction with the AARC’s International Congress.

The ARCF will provide MMC (sponsor of the award) with an annual accounting of the MAB Achievement Award endowment, including the balance, investment income, and disbursements. The date of such accounting to be set by the ARCF to coincide with the filing of its year’s end audited financial statements.

Any changes to the criteria or process for judging/selecting MAB Award recipients, or the Award itself, must have prior written approval from MMC.

Sponsor Details

Sponsor Institute/Organizations: American Respiratory Care Foundation

Sponsor Type: Corporate/Non-Profit

Address: 16479 Dallas Parkway Ste 420 Addison, TX 75001

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity